title: Uterine motor alterations and estrous cycle disturbances associated with colonic inflammation in the rat.
abstract: The impact of colitis on uterine contractility and estrous cycle was investigated after intracolonic administration of 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats. Colitis severity was assessed by macroscopic damage scoring (MDS) 4 days after TNBS, and myeloperoxidase (MPO) activity was measured in both colon and uterus of control and colitic rats. Estrous cycle stages were determined by vaginal smears and histology, and uterine contractility was assessed in vitro on longitudinal and circular strips. In control rats, uterine MPO activity varied markedly during the cycle and peaked around estrus. In rats with moderate colitis [MDS < 5, 3.1 +/- 0.2 (mean +/- SE)], uterine MPO decreased by 61% compared with estrus control, without disruption of the cycle. Frequency of spontaneous contractions was reduced by 32% in circular muscle. Contractile responses to KCl and carbachol were not affected, whereas maximal response to oxytocin decreased by 47% in the longitudinal muscle. In rats with severe colitis (MDS > 5, 6.0 +/- 0.2), uterine MPO was reduced by 96% and estrous cycle was disrupted. Spontaneous contractility was impaired in circular strips, and a 39% decrease in the contraction frequency occurred in the longitudinal strips. Circular strips did not contract to KCl or carbachol; however, longitudinal strips had maximal responses to KCl, carbachol, and oxytocin reduced by 36%, 27%, and 46%, respectively. Estrogen replacement protected the uterine responses to carbachol in colitic rats, whereas oxytocin responses remained depressed. These data indicate that colonic inflammation can influence both spontaneous and evoked uterine contractility, in relation to estrous cycle disturbances, impaired estradiol production, and functional alterations of myometrial cells.
authors.affiliation: Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, 180 chemin de Tournefeuille BP3, F-31931 Toulouse Cedex 9, France. houdeau@toulouse.inra.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Houdeau
authors.forename: Muriel
authors.initials: M
authors.lastname: Larauche
authors.forename: Régine
authors.initials: R
authors.lastname: Monnerie
authors.forename: Lionel
authors.initials: L
authors.lastname: Bueno
authors.forename: Jean
authors.initials: J
authors.lastname: Fioramonti
mesh_terms: D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D003092:Colitis / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology*; D003106:Colon / Q000201:enzymology / Q000473:pathology; D004971:Estrus / Q000378:metabolism; D005260:Female; D066298:In Vitro Techniques; D018721:Muscarinic Agonists / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D009195:Peroxidase / Q000378:metabolism; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014302:Trinitrobenzenesulfonic Acid; D014590:Uterine Contraction / Q000187:drug effects; D014599:Uterus / Q000187:drug effects / Q000201:enzymology
chemical_list: D018721:Muscarinic Agonists; D010121:Oxytocin; D011189:Potassium Chloride; D014302:Trinitrobenzenesulfonic Acid; D002217:Carbachol; D009195:Peroxidase